NCT00259610View on ClinicalTrials.gov

Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

PHASE4CompletedINTERVENTIONAL
Enrollment

755

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

methotrexate

varies

DRUG

sulfasalazine

varies

DRUG

hydroxychloroquine

varies

DRUG

etanercept

varies

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors
All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

Barr Laboratories

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

University of Alabama at Birmingham

OTHER